Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Synovial Cyst 1Spondylosis 1Spondylolisthesis 1Spinal Stenosis 1Radiculopathy 1Intervertebral Disc Displacement 1Intervertebral Disc Degeneration 1Hot Flashes 1Carcinoma, Renal Cell 1Breast Neoplasms 1Agnosia 1

Interventions

Morphine 2Bupivacaine 2Anesthesia, Local 2Analgesia, Epidural 2engage 8200 1Transdermal Patch 1Touch 1Telemedicine 1Surgical Instruments 1Ropivacaine 1Radiosurgery 1Radiofrequency Ablation 1Psilocybin 1Palliative Care 1Methods 1Ketorolac 1Hydromorphone 1Exercise 1Epinephrine 1Electroencephalography 1Dipyrone 1Cryosurgery 1Clonidine 1Capsaicin 1Botulinum Toxins, Type A 1Anesthesia, Spinal 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Agnosia × Clonidine × Clear all
NCT07092566 2026-01-20

R.E.C.K vs Exparel in Robotic Nephrectomy

Wake Forest University Health Sciences

Phase 3 Recruiting
170 enrolled
Genitourinary

Agnosia, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡